Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Calligaro

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|November 16, 2001
N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapyY C Xu, K W Johnson, L A Phebus, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activityH E Shannon, M J Sheardown, F P Bymaster, et al.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Journal of Medicinal Chemistry|February 14, 1997
Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndromeC H Mitch, T J Brown, F P Bymaster, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2000
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetineK Rasmussen, D O Calligaro, J F Czachura, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Medicinal Chemistry|November 16, 2001
N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapyY C Xu, K W Johnson, L A Phebus, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activityH E Shannon, M J Sheardown, F P Bymaster, et al.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Journal of Medicinal Chemistry|February 14, 1997
Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndromeC H Mitch, T J Brown, F P Bymaster, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2000
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetineK Rasmussen, D O Calligaro, J F Czachura, et al.
Pageof 5